Clinical Trials Browser

Not yet recruiting × Bone Neoplasms × alectinib × Clear all

NCT07560410 2026-05-11

Treatment of Truncated ALK-positive Bone Cancer Using Crizotinib (Xalkori) or Alectinib (Alecensa)

Phase 1/2 Not yet recruiting

Bone Neoplasms